Gifford David R.
Gifford David R., DIR, reported a transaction classified as grant at NATIONAL HEALTHCARE CORP involving 4691.000000 shares for an estimated $1110594.25. Reported holdings after the transaction were 2809.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 20, 2026
- Filing date
- Aug 21, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
NHC price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001437749-26-028735 Common Stock
- Transaction date
- Aug 20, 2026 Filed Aug 21, 2026, 08:11 PM · 1d delay
- Shares
- 4,691 sh $236.75 per share
- Estimated value
- -$1.11M Computed from shares × price
- Holdings after
- 2,809 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - grant_or_award-22 points
transaction_code = A
Grant or award transactions are scheduled compensation, not discretionary.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d…
- F2
Shares were withheld by the Company to pay the exercise price.
- F3
Total amount of shares beneficially owned following transactions reported on this form.
0 other transactions
0 recent txs